PRECISEU Matchmaking Platform

20 Oct 2025 – 30 Apr 2026 | Barcelona, Spain

Register
Register
Register

Business OpportunityUpdated on 8 May 2026

Digital biomarkers

CEO at Ephion Health

Barcelona, Spain

About

Ephion Health is a digital health company delivering a hardware-agnostic AI platform that transforms mobility data into clinically validated digital biomarkers. We generate objective, sensitive measures of functional capacity in people with mobility-impairing diseases, enabling pharma companies to de-risk drug development and providing clinicians with precise, data-driven decision-support tools.

By shifting the primary endpoint from in-clinic tests to remote monitoring (e.g., a remote 10-meter walk), we reduce the "friction" and burden on patients. This promotes equity of access, allowing patients in remote areas to participate in high-quality clinical research and receive personalized monitoring without frequent travel.

Ephion establishes an automated data pipeline that turns complex biomechanical data into standardized insights. This facilitates a shift from reactive patient monitoring to early diagnosis and preventive medicine, with the long-term goal of identifying health risks before physical symptoms even appear.

Stage

  • TRL 8

Topic

  • Congenital or chromosomal abnormalities
  • Musculoskeletal system, connective tissue
  • Diseases of the nervous system / neurology
  • Pediatrics
  • Rare diseases

Sector

  • Health data
  • AI
  • Diagnostics
  • Rare diseases

Type

  • Research collaboration
  • Co-development
  • Clinical validation

Organisation

Ephion Health

SME

Barcelona, Spain

Similar opportunities

  • Business Opportunity

    Barcelona Children’s Hospital Sant Joan de Déu (HSJD): Health Data and ATMPs for Personalised Medicine

    • TRL 6
    • ATMPs
    • Oncology
    • Pediatrics
    • Health data
    • Diagnostics
    • Rare diseases
    • Rare diseases
    • Clinical validation
    • Research collaboration
    • Congenital or chromosomal abnormalities
    • Pregnancy, childbirth and the puerperium
    • Diseases of the blood and immune disorders
    • Diseases of the nervous system / neurology

    Fundacio Recerca Sant Joan de Deu

    Pre-Award Project Manager at Barcelona Children's Hospital Sant Joan de Déu / Research Institute

    Esplugues de Llobregat, Spain

  • Business Opportunity

    NextPIDCAP: Implementing a standardized clinical decision support tool to enhance early identification of primary immunodeficiencies

    • TRL 6
    • TRL 7
    • TRL 8
    • Health data
    • Rare diseases
    • Research collaboration
    • Congenital or chromosomal abnormalities
    • Diseases of the blood and immune disorders

    Jacques Riviere

    Pediatric immunologist, researcher at Vall d'Hebron Research Institute (VHIR)

    Barcelona, Spain

  • Business Opportunity

    vitalera: Making Hospital-at-Home a Reality with AI

    • AI
    • TRL 8
    • Oncology
    • Physiology
    • Pediatrics
    • Licensing
    • Respiratory
    • Health data
    • Rare diseases
    • Rare diseases
    • Bioinformatics
    • Cardiovascular
    • Co-development
    • Digestive system
    • Consortium partners
    • Regenerative medicine
    • Research collaboration
    • External causes of morbidity, mortality
    • Injury, poisoning, other external causes
    • Pregnancy, childbirth and the puerperium
    • Musculoskeletal system, connective tissue
    • Other symptoms, deviant clinical findings
    • Diseases of the blood and immune disorders
    • Diseases of the nervous system / neurology
    • Mental and behavioural disorders / psychiatry /psychology

    Nuria Pastor

    General Manager at vitalera

    Barcelona, Spain